Conavi Medical Corp.
CNVIF
$0.19
$0.0213.65%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.12% | 61.39% | 58.17% | 72.97% | 58.71% |
| Total Depreciation and Amortization | -14.20% | -16.02% | 24.21% | -17.57% | -24.06% |
| Total Amortization of Deferred Charges | -- | -- | -82.15% | -- | -- |
| Total Other Non-Cash Items | 118.03% | -234.87% | -77.23% | -120.09% | -262.50% |
| Change in Net Operating Assets | -262.31% | 153.34% | -141.07% | -212.17% | 77.20% |
| Cash from Operations | -89.85% | 51.16% | -10.45% | -40.23% | 26.71% |
| Capital Expenditure | 80.85% | -3.86% | 93.14% | 94.55% | 74.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,412.24% | -103.09% | -87.25% | 100.00% | 78.03% |
| Cash from Investing | -227.85% | -103.92% | 51.92% | 95.86% | 75.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -32.44% | -12.79% | -77.06% | -91.93% | -120.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,960.60% | -105.04% | -110.70% | 301.06% | -114.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.66% | -205.07% | -311.36% | 965.41% | 23.34% |